{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:34:26Z","timestamp":1777433666529,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.neuint.2019.104518","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T06:53:56Z","timestamp":1564728836000},"page":"104518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Somatostatin and cannabinoid receptors crosstalk in protection of huntingtin knock-in striatal neuronal cells in response to quinolinic acid"],"prefix":"10.1016","volume":"129","author":[{"given":"Shenglong","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ujendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2019.104518_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ana.410130508","article-title":"Somatostatin is increased in the basal ganglia in Huntington disease","volume":"13","author":"Aronin","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2019.104518_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/mol.116.103465","article-title":"Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons","volume":"89","author":"Bagher","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104518_bib3","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.cellsig.2007.07.007","article-title":"Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 - Co-immunoprecipitation and fluorescence resonance energy transfer analysis","volume":"19","author":"Baragli","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuint.2019.104518_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/syn.890020415","article-title":"Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes","volume":"2","author":"Beal","year":"1988","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2019.104518_bib5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble huntingtons-disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuint.2019.104518_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of huntingtons-disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2019.104518_bib7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB1 receptors regulate neuronal energy metabolism","volume":"15","author":"Benard","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2019.104518_bib8","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Blazquez","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuint.2019.104518_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.neuint.2019.104518_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2008.01.014","article-title":"Somatostatin and Alzheimer's disease","volume":"286","author":"Burgos-Ramos","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuint.2019.104518_bib11","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Callen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2019.104518_bib12","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"P. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2019.104518_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"Daigle","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2019.104518_bib14","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/j.1476-5381.2011.01455.x","article-title":"Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine\/threonine kinases to activate ERK in neuronal cells","volume":"165","author":"Dalton","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104518_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurons in huntingtons-disease","volume":"340","author":"Dawbarn","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2019.104518_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","article-title":"The role of excitotoxicity in neurodegenerative disease: implications for therapy","volume":"81","author":"Doble","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2019.104518_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0006-8993(83)90277-9","article-title":"Somatostatin and dementia in Parkinsons-disease","volume":"278","author":"Epelbaum","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2019.104518_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2019.104518_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in huntingtons-disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neuint.2019.104518_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuint.2019.104518_bib21","doi-asserted-by":"crossref","first-page":"21537","DOI":"10.1074\/jbc.M109.084202","article-title":"Impaired TrkB-mediated ERK1\/2 activation in Huntington disease knock-in striatal cells involves reduced p52\/p46 shc expression","volume":"285","author":"Gines","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2019.104518_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2019.104518_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia-Nigra in huntingtons-disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2019.104518_bib24","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuint.2019.104518_bib25","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1210\/me.2007-0334","article-title":"Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization","volume":"22","author":"Grant","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neuint.2019.104518_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2019.104518_bib27","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuint.2019.104518_bib28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/jpet.103.057620","article-title":"D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor","volume":"308","author":"Jarrahian","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuint.2019.104518_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuint.2019.104518_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2019.104518_bib31","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuint.2019.104518_bib32","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1124\/mol.104.006882","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?","volume":"67","author":"Kearn","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104518_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/mol.105.016428","article-title":"Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity","volume":"69","author":"Kim","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104518_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neures.2004.01.011","article-title":"Characterization of striatal cultures with the effect of QUIN and NMDA","volume":"49","author":"Kumar","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuint.2019.104518_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cne.21444","article-title":"Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus","volume":"504","author":"Kumar","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2019.104518_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12031-008-9093-3","article-title":"Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-methyl-D-asparate-induced neurotoxicity","volume":"35","author":"Kumar","year":"2008","journal-title":"J. Mol. Neurosci. : MN"},{"key":"10.1016\/j.neuint.2019.104518_bib37","first-page":"137","article-title":"Somatostatin and somatostatin receptors","volume":"50","author":"Kumar","year":"2010","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.neuint.2019.104518_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diabetes.48.1.77","article-title":"Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis","volume":"48","author":"Kumar","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.neuint.2019.104518_bib39","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1523\/JNEUROSCI.15-07-05297.1995","article-title":"NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum","volume":"15","author":"Landwehrmeyer","year":"1995","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuint.2019.104518_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2013.04.006","article-title":"Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease","volume":"72","author":"Laprairie","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2019.104518_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fphar.2013.00110","article-title":"Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?","volume":"4","author":"Lin","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104518_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","author":"Mackie","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104518_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuint.2019.104518_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/pr.110.003491","article-title":"The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications","volume":"63","author":"Miller","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2019.104518_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2014.08.009","article-title":"Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice","volume":"71","author":"Naydenov","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2019.104518_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2019.104518_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuint.2019.104518_bib48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2019.104518_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/2013\/705373","article-title":"The pathophysiology and pharmacological treatment of Huntington disease","volume":"26","author":"Pidgeon","year":"2013","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.neuint.2019.104518_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024467","article-title":"Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice","volume":"6","author":"Rajput","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2019.104518_bib51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuint.2019.104518_bib52","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1074\/jbc.275.11.7862","article-title":"Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers","volume":"275","author":"Rocheville","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2019.104518_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0854.2010.01130.x","article-title":"Type I cannabinoid receptor trafficking: all roads lead to lysosome","volume":"12","author":"Rozenfeld","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.neuint.2019.104518_bib54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/hmg\/ddh082","article-title":"Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway","volume":"13","author":"Ruan","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2019.104518_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2008.05.048","article-title":"Cannabinoids and hamster circadian activity rhythms","volume":"1222","author":"Sanford","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2019.104518_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0301-0082(96)00030-5","article-title":"Somatostatin receptors in the central nervous system","volume":"50","author":"Schindler","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2019.104518_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0404.1987.tb07912.x","article-title":"Somatostatin in multiple sclerosis","volume":"75","author":"Sorensen","year":"1987","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuint.2019.104518_bib58","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2007.12.004","article-title":"Somatostatin: an endogenous antiepileptic","volume":"286","author":"Tallent","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuint.2019.104518_bib59","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2019.104518_bib60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/npp.2010.214","article-title":"Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation","volume":"36","author":"Zoppi","year":"2011","journal-title":"Neuropsychopharmacology: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2019.104518_bib61","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2015.06.021","article-title":"Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus","volume":"1622","author":"Zou","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2019.104518_bib62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12031-014-0369-5","article-title":"Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hypothalamus","volume":"55","author":"Zou","year":"2015","journal-title":"J. Mol. Neurosci. : MN"},{"key":"10.1016\/j.neuint.2019.104518_bib63","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuroscience.2016.10.056","article-title":"Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of cannabinoid receptors 1","volume":"340","author":"Zou","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2019.104518_bib64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018619303110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018619303110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:52:17Z","timestamp":1759312337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018619303110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":64,"alternative-id":["S0197018619303110"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2019.104518","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatostatin and cannabinoid receptors crosstalk in protection of huntingtin knock-in striatal neuronal cells in response to quinolinic acid","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2019.104518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104518"}}